| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ALK-FISH borderline cases in non-small cell lung cancer: Implications for diagnostics and clinical decision making
|
von Laffert, Maximilian
|
|
2015
|
90 |
3 |
p. 465-471
7 p.
|
artikel
|
| 2 |
Altered purinergic signaling in the tumor associated immunologic microenvironment in metastasized non-small-cell lung cancer
|
Schmid, Severin
|
|
2015
|
90 |
3 |
p. 516-521
6 p.
|
artikel
|
| 3 |
A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model
|
Mangoni, Monica
|
|
2015
|
90 |
3 |
p. 405-409
5 p.
|
artikel
|
| 4 |
A randomized Phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II Non-Small-Cell Lung Cancer
|
Schmid-Bindert, Gerald
|
|
2015
|
90 |
3 |
p. 397-404
8 p.
|
artikel
|
| 5 |
Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma
|
Santarelli, Lory
|
|
2015
|
90 |
3 |
p. 457-464
8 p.
|
artikel
|
| 6 |
Comparing four different ALK antibodies with manual immunohistochemistry (IHC) to screen for ALK-rearranged non-small cell lung cancer (NSCLC)
|
Shen, Qin
|
|
2015
|
90 |
3 |
p. 492-498
7 p.
|
artikel
|
| 7 |
Contents
|
|
|
2015
|
90 |
3 |
p. v-vii
nvt p.
|
artikel
|
| 8 |
Divergent epidermal growth factor receptor mutation patterns between smokers and non-smokers with lung adenocarcinoma
|
Tseng, Jeng-Sen
|
|
2015
|
90 |
3 |
p. 472-476
5 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2015
|
90 |
3 |
p. iii-
1 p.
|
artikel
|
| 10 |
EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291
|
Thress, Kenneth S.
|
|
2015
|
90 |
3 |
p. 509-515
7 p.
|
artikel
|
| 11 |
Endosonography for lung cancer staging: predictors for false-negative outcomes
|
Talebian Yazdi, Mehrdad
|
|
2015
|
90 |
3 |
p. 451-456
6 p.
|
artikel
|
| 12 |
Evaluation of palonosetron and dexamethasone with or without aprepitant to prevent carboplatin-induced nausea and vomiting in patients with advanced non-small-cell lung cancer
|
Kusagaya, Hideki
|
|
2015
|
90 |
3 |
p. 410-416
7 p.
|
artikel
|
| 13 |
Expression of epigenetic modifiers is not significantly altered by exposure to secondhand smoke
|
Tommasi, Stella
|
|
2015
|
90 |
3 |
p. 598-603
6 p.
|
artikel
|
| 14 |
First line crizotinib in anaplastic lymphoma kinase (ALK) rearranged squamous cell lung cancer
|
Mikes, Romana E.
|
|
2015
|
90 |
3 |
p. 614-616
3 p.
|
artikel
|
| 15 |
HER2 insertion YVMA mutant lung cancer: Long natural history and response to afatinib
|
Li, Bob T.
|
|
2015
|
90 |
3 |
p. 617-619
3 p.
|
artikel
|
| 16 |
Is there a specific phenotype associated with the different subtypes of KRAS mutations in patients with advanced non-small-cell lung cancers?
|
Dumenil, Coraline
|
|
2015
|
90 |
3 |
p. 561-567
7 p.
|
artikel
|
| 17 |
Lung cancer survival in Germany: A population-based analysis of 132,612 lung cancer patients
|
Eberle, Andrea
|
|
2015
|
90 |
3 |
p. 528-533
6 p.
|
artikel
|
| 18 |
MET amplification, protein expression, and mutations in pulmonary adenocarcinoma
|
Park, Seongyeol
|
|
2015
|
90 |
3 |
p. 381-387
7 p.
|
artikel
|
| 19 |
MET gene exon 14 deletion created using the CRISPR/Cas9 system enhances cellular growth and sensitivity to a MET inhibitor
|
Togashi, Yosuke
|
|
2015
|
90 |
3 |
p. 590-597
8 p.
|
artikel
|
| 20 |
Non-coding RNA repertoires in malignant pleural mesothelioma
|
Quinn, Leah
|
|
2015
|
90 |
3 |
p. 417-426
10 p.
|
artikel
|
| 21 |
Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma
|
Mäkinen, Johanna M.
|
|
2015
|
90 |
3 |
p. 568-574
7 p.
|
artikel
|
| 22 |
Non-small cell lung cancer patients with brain metastases treated with first-line platinum-doublet chemotherapy: Analysis from the European FRAME study
|
Moro-Sibilot, Denis
|
|
2015
|
90 |
3 |
p. 427-432
6 p.
|
artikel
|
| 23 |
NUT carcinoma of the thorax: Case report and review of the literature
|
Harms, Alexander
|
|
2015
|
90 |
3 |
p. 484-491
8 p.
|
artikel
|
| 24 |
Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancer
|
Gerber, David E.
|
|
2015
|
90 |
3 |
p. 534-541
8 p.
|
artikel
|
| 25 |
Predictive and prognostic value of de novo MET expression in patients with advanced non-small-cell lung cancer
|
Li, Anna
|
|
2015
|
90 |
3 |
p. 375-380
6 p.
|
artikel
|
| 26 |
Prognostic impact of clinical variables on surgically resected small-cell lung cancer: Results of a retrospective multicenter analysis (FIGHT002A and HOT1301A)
|
Yokouchi, Hiroshi
|
|
2015
|
90 |
3 |
p. 548-553
6 p.
|
artikel
|
| 27 |
Prognostic impact of pattern-based grading system by the new IASLC/ATS/ERS classification in Asian patients with stage I lung adenocarcinoma
|
Zhao, Ze-Rui
|
|
2015
|
90 |
3 |
p. 604-609
6 p.
|
artikel
|
| 28 |
Racial and geographic disparities in the patterns of care and costs at the end of life for patients with lung cancer in 2007–2010 after the 2006 introduction of bevacizumab
|
Du, Xianglin L.
|
|
2015
|
90 |
3 |
p. 442-450
9 p.
|
artikel
|
| 29 |
Radiation therapy (RT) and chemotherapy (CHT) in stage II non-small cell lung cancer (NSCLC): Clinical entity neglected by radiation oncologists?
|
Jeremic, Branislav
|
|
2015
|
90 |
3 |
p. 622-623
2 p.
|
artikel
|
| 30 |
RECIST progression patterns during EGFR tyrosine kinase inhibitor treatment of advanced non-small cell lung cancer patients harboring an EGFR mutation
|
Yoshida, Tatsuya
|
|
2015
|
90 |
3 |
p. 477-483
7 p.
|
artikel
|
| 31 |
Reproductive factors and lung cancer risk among women in the Singapore Breast Cancer Screening Project
|
Tan, Hui Shan
|
|
2015
|
90 |
3 |
p. 499-508
10 p.
|
artikel
|
| 32 |
Response evaluation in mesothelioma: Beyond RECIST
|
Cheng, Lin
|
|
2015
|
90 |
3 |
p. 433-441
9 p.
|
artikel
|
| 33 |
Responses to the multitargeted MET/ALK/ROS1 inhibitor crizotinib and co-occurring mutations in lung adenocarcinomas with MET amplification or MET exon 14 skipping mutation
|
Jorge, Susan E.
|
|
2015
|
90 |
3 |
p. 369-374
6 p.
|
artikel
|
| 34 |
Stereotactic body radiotherapy for early stage lung cancer: History and updated role
|
Ricardi, Umberto
|
|
2015
|
90 |
3 |
p. 388-396
9 p.
|
artikel
|
| 35 |
Successful treatment with alectinib after crizotinib-induced interstitial lung disease
|
Chino, Haruka
|
|
2015
|
90 |
3 |
p. 610-613
4 p.
|
artikel
|
| 36 |
Take-home message in times of crisis: Is it really better to treat with cisplatin & pemetrexed than cisplatin & gemcitabine in first line NSCLC? The power of statistical considerations
|
Rolfo, Christian
|
|
2015
|
90 |
3 |
p. 620-622
3 p.
|
artikel
|
| 37 |
The impact of tumor size on the association of the extent of lymph node resection and survival in clinical stage I non-small cell lung cancer
|
Gulack, Brian C.
|
|
2015
|
90 |
3 |
p. 554-560
7 p.
|
artikel
|
| 38 |
The performance of a novel amino acid multivariate index for detecting lung cancer: A case control study in Korea
|
Kim, Hee Joung
|
|
2015
|
90 |
3 |
p. 522-527
6 p.
|
artikel
|
| 39 |
Treatment of isolated mediastinal and hilar recurrence of lung cancer with bronchoscopic endobronchial ultrasound guided intratumoral injection of chemotherapy with cisplatin
|
Mehta, Hiren J.
|
|
2015
|
90 |
3 |
p. 542-547
6 p.
|
artikel
|
| 40 |
We’re in this together: Patients’, caregivers’ and health care providers’ illness perceptions about non-small-cell lung cancer (NSCLC)
|
Kaptein, Ad A.
|
|
2015
|
90 |
3 |
p. 575-581
7 p.
|
artikel
|
| 41 |
When is surgery indicated for small-cell lung cancer?
|
Veronesi, Giulia
|
|
2015
|
90 |
3 |
p. 582-589
8 p.
|
artikel
|
Tijdschrift beschrijving